These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 15844621)

  • 1. Allosteric aptamers and aptazymes as probes for screening approaches.
    Famulok M
    Curr Opin Mol Ther; 2005 Apr; 7(2):137-43. PubMed ID: 15844621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conditional RNA interference mediated by allosteric ribozyme.
    Kumar D; An CI; Yokobayashi Y
    J Am Chem Soc; 2009 Oct; 131(39):13906-7. PubMed ID: 19788322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineering high-speed allosteric hammerhead ribozymes.
    Link KH; Guo L; Ames TD; Yen L; Mulligan RC; Breaker RR
    Biol Chem; 2007 Aug; 388(8):779-86. PubMed ID: 17655496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineering allosteric regulation into biological catalysts.
    Fastrez J
    Chembiochem; 2009 Dec; 10(18):2824-35. PubMed ID: 19937897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computational design and experimental validation of oligonucleotide-sensing allosteric ribozymes.
    Penchovsky R; Breaker RR
    Nat Biotechnol; 2005 Nov; 23(11):1424-33. PubMed ID: 16244657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allosteric aptamers: targeted reversibly attenuated probes.
    Cong X; Nilsen-Hamilton M
    Biochemistry; 2005 Jun; 44(22):7945-54. PubMed ID: 15924413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computational design of allosteric ribozymes as molecular biosensors.
    Penchovsky R
    Biotechnol Adv; 2014; 32(5):1015-27. PubMed ID: 24877999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ADLOC: an aptamer-displacement assay based on luminescent oxygen channeling.
    Niebel B; Lentz C; Pofahl M; Mayer G; Hoerauf A; Pfarr KM; Famulok M
    Chemistry; 2010 Sep; 16(36):11100-7. PubMed ID: 20690121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein-dependent ribozymes report molecular interactions in real time.
    Hartig JS; Najafi-Shoushtari SH; Grüne I; Yan A; Ellington AD; Famulok M
    Nat Biotechnol; 2002 Jul; 20(7):717-22. PubMed ID: 12089558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional nucleic acids in high throughput screening and drug discovery.
    Srivatsan SG; Famulok M
    Comb Chem High Throughput Screen; 2007 Sep; 10(8):698-705. PubMed ID: 18045081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The case of the missing allosteric ribozymes.
    Panchapakesan SSS; Breaker RR
    Nat Chem Biol; 2021 Apr; 17(4):375-382. PubMed ID: 33495645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural and engineered nucleic acids as tools to explore biology.
    Breaker RR
    Nature; 2004 Dec; 432(7019):838-45. PubMed ID: 15602549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selection in vitro of allosteric ribozymes.
    Roth A; Breaker RR
    Methods Mol Biol; 2004; 252():145-64. PubMed ID: 15017047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA aptamer-mediated regulation of the hairpin ribozyme by human alpha-thrombin.
    Najafi-Shoushtari SH; Famulok M
    Blood Cells Mol Dis; 2007; 38(1):19-24. PubMed ID: 17150386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oligonucleotide aptamers that recognize small molecules.
    Famulok M
    Curr Opin Struct Biol; 1999 Jun; 9(3):324-9. PubMed ID: 10361088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allosterically controllable maxizymes for molecular gene therapy.
    Iyo M; Kawasaki H; Taira K
    Curr Opin Mol Ther; 2002 Apr; 4(2):154-65. PubMed ID: 12044037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Group I aptazymes as genetic regulatory switches.
    Thompson KM; Syrett HA; Knudsen SM; Ellington AD
    BMC Biotechnol; 2002 Dec; 2():21. PubMed ID: 12466025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aptazymes: Expanding the Specificity of Natural Catalytic Nucleic Acids by Application of In Vitro Selected Oligonucleotides.
    Walter JG; Stahl F
    Adv Biochem Eng Biotechnol; 2020; 170():107-119. PubMed ID: 30847536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aptamers and aptazymes: accelerating small molecule drug discovery.
    Burgstaller P; Jenne A; Blind M
    Curr Opin Drug Discov Devel; 2002 Sep; 5(5):690-700. PubMed ID: 12630289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SELEX--a (r)evolutionary method to generate high-affinity nucleic acid ligands.
    Stoltenburg R; Reinemann C; Strehlitz B
    Biomol Eng; 2007 Oct; 24(4):381-403. PubMed ID: 17627883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.